# Selenomethionine in Treating Patients Undergoing Surgery or Internal Radiation Therapy for Stage I or Stage II Prostate Cancer

> **NCT00736164** · PHASE2 · WITHDRAWN · sponsor: **Roswell Park Cancer Institute**

## Conditions studied

- Prostate Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** selenomethionine
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00736164
- **Lead sponsor:** Roswell Park Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-08
- **Primary completion:** 2012-06
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No accrual
- **Last updated:** 2012-02-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00736164

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00736164, "Selenomethionine in Treating Patients Undergoing Surgery or Internal Radiation Therapy for Stage I or Stage II Prostate Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00736164. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*